These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 33371882)

  • 1. Immunological biomarkers of the vitreous responsible for proliferative alteration in the different forms of retinal detachment.
    Balogh A; Milibák T; Szabó V; Nagy ZZ; Kaarniranta K; Resch MD
    BMC Ophthalmol; 2020 Dec; 20(1):491. PubMed ID: 33371882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Position of macula lutea and presence of proliferative vitreoretinopathy affect vitreous cytokine expression in rhegmatogenous retinal detachment.
    Balogh A; Milibák T; Szabó V; Nagy ZZ; Resch MD
    PLoS One; 2020; 15(6):e0234525. PubMed ID: 32542038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
    Tomé CC; De Rojas Silva MV; Rodríguez-García J; Rodríguez-Segade S; Sánchez-Salorio M
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
    Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Capeans C; De Rojas MV; Lojo S; Salorio MS
    Retina; 1998; 18(6):546-50. PubMed ID: 9869464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Barile GR; Chang SS; Park LS; Reppucci VS; Schiff WM; Schmidt AM
    Curr Eye Res; 1999 Sep; 19(3):219-27. PubMed ID: 10487959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble TNF receptors in vitreoretinal proliferative disease.
    Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of thrombin in proliferative vitreoretinopathy.
    Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Serum and Vitreous Inflammation-Related Factor Profiles in Patients with Proliferative Vitreoretinopathy.
    Ni Y; Qin Y; Huang Z; Liu F; Zhang S; Zhang Z
    Adv Ther; 2020 May; 37(5):2550-2559. PubMed ID: 32274748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INCREASED COMPLEMENT LEVELS IN HUMAN VITREOUS ASPIRATES OF PROLIFERATIVE DIABETIC RETINOPATHY AND RETINAL DETACHMENT EYES.
    Manoharan N; Patnaik JL; Olson JL
    Retina; 2019 Nov; 39(11):2212-2218. PubMed ID: 30148749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CONCENTRATIONS OF VITREAL CYTOKINES IN RHEGMATOGENOUS RETINAL DETACHMENT.
    Danielescu C; Zugun-Eloae F; Zlei M
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):124-9. PubMed ID: 27125084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy.
    Canataroglu H; Varinli I; Ozcan AA; Canataroglu A; Doran F; Varinli S
    Ocul Immunol Inflamm; 2005; 13(5):375-81. PubMed ID: 16422002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy.
    Wang Y; Gao S; Zhu Y; Shen X
    Curr Eye Res; 2017 Aug; 42(8):1202-1208. PubMed ID: 28497987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Level of Vascular Endothelial Growth Factor in the Vitreous Fluid of Proliferative Diabetic Retinopathy Patients and Prognosis after Vitrectomy.
    Suzuki Y; Suzuki K; Kudo T; Metoki T; Nakazawa M
    Ophthalmologica; 2016; 236(3):133-138. PubMed ID: 27794575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of some cytokines in subretinal fluid in proliferative vitreoretinopathy and rhegmatogenous retinal detachment.
    Kenarova B; Voinov L; Apostolov C; Vladimirova R; Misheva A
    Eur J Ophthalmol; 1997; 7(1):64-7. PubMed ID: 9101198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Elner SG; Elner VM; Jaffe GJ; Stuart A; Kunkel SL; Strieter RM
    Curr Eye Res; 1995 Nov; 14(11):1045-53. PubMed ID: 8585935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of chemokines and growth factors in proliferative diabetic retinopathy vitreous.
    Dai Y; Wu Z; Wang F; Zhang Z; Yu M
    Biomed Res Int; 2014; 2014():486386. PubMed ID: 25401103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion.
    Suzuki Y; Nakazawa M; Suzuki K; Yamazaki H; Miyagawa Y
    Jpn J Ophthalmol; 2011 May; 55(3):256-263. PubMed ID: 21538000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.